352 related articles for article (PubMed ID: 37298575)
21. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B & C virus infection in HIV seropositive individuals & their association with risk factors: A hospital-based study.
Sharma V; Ramachandran VG; Mogha NS; Bharadwaj M
Indian J Med Res; 2018 Jun; 147(6):588-593. PubMed ID: 30168491
[TBL] [Abstract][Full Text] [Related]
24. Toll-Like Receptor Response to Hepatitis B Virus Infection and Potential of TLR Agonists as Immunomodulators for Treating Chronic Hepatitis B: An Overview.
Kayesh MEH; Kohara M; Tsukiyama-Kohara K
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638802
[TBL] [Abstract][Full Text] [Related]
25. The prevalence of hepatitis B and C in HIV-positive Greek patients: relationship to survival of deceased AIDS patients.
Dimitrakopoulos A; Takou A; Haida A; Molangeli S; Gialeraki A; Kordossis T
J Infect; 2000 Mar; 40(2):127-31. PubMed ID: 10841086
[TBL] [Abstract][Full Text] [Related]
26. Interference of replication between hepatitis B and C viruses in patients infected with HIV.
Yang RR; Gui X; Chen XY; Zhu Y
J Med Virol; 2011 Jul; 83(7):1159-64. PubMed ID: 21567419
[TBL] [Abstract][Full Text] [Related]
27. Sero-prevalence of Hepatitis B and C viral co-infections among HIV-1 infected ART-naïve individuals in Kumasi, Ghana.
Boateng R; Mutocheluh M; Dompreh A; Obiri-Yeboah D; Odame Anto E; Owusu M; Narkwa PW
PLoS One; 2019; 14(4):e0215377. PubMed ID: 31002687
[TBL] [Abstract][Full Text] [Related]
28. Role of unsafe medical practices and sexual behaviours in the hepatitis B and C syndemic and HIV co-infection in Rwanda: a cross-sectional study.
Makuza JD; Nisingizwe MP; Rwema JOT; Dushimiyimana D; Habimana DS; Umuraza S; Serumondo J; Ngwije A; Semakula M; Gupta N; Nsanzimana S; Janjua NZ
BMJ Open; 2020 Jul; 10(7):e036711. PubMed ID: 32660951
[TBL] [Abstract][Full Text] [Related]
29. HIV-HBV and HIV-HCV Coinfection and Liver Cancer Development.
Hu J; Liu K; Luo J
Cancer Treat Res; 2019; 177():231-250. PubMed ID: 30523627
[TBL] [Abstract][Full Text] [Related]
30. Replication Inhibition of Hepatitis B Virus and Hepatitis C Virus in Co-Infected Patients in Chinese Population.
Yu G; Chi X; Wu R; Wang X; Gao X; Kong F; Feng X; Gao Y; Huang X; Jin J; Qi Y; Tu Z; Sun B; Zhong J; Pan Y; Niu J
PLoS One; 2015; 10(9):e0139015. PubMed ID: 26422607
[TBL] [Abstract][Full Text] [Related]
31. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.
Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P
World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773
[TBL] [Abstract][Full Text] [Related]
32. HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: A retrospective cross-sectional study.
Seyoum E; Demissie M; Worku A; Mulu A; Abdissa A; Berhane Y
PLoS One; 2022; 17(4):e0267230. PubMed ID: 35452472
[TBL] [Abstract][Full Text] [Related]
33. Toll-like receptor-mediated innate immunity orchestrates adaptive immune responses in HBV infection.
Du Y; Wu J; Liu J; Zheng X; Yang D; Lu M
Front Immunol; 2022; 13():965018. PubMed ID: 35967443
[TBL] [Abstract][Full Text] [Related]
34. Overt and occult hepatitis B virus infection in adult Sudanese HIV patients.
Mudawi H; Hussein W; Mukhtar M; Yousif M; Nemeri O; Glebe D; Kramvis A
Int J Infect Dis; 2014 Dec; 29():65-70. PubMed ID: 25449238
[TBL] [Abstract][Full Text] [Related]
35. Advances in the treatment of hepatitis B virus/hepatitis C virus coinfection.
Sagnelli E; Pisaturo M; Martini S; Sagnelli C; Filippini P; Coppola N
Expert Opin Pharmacother; 2014 Jul; 15(10):1337-49. PubMed ID: 24773464
[TBL] [Abstract][Full Text] [Related]
36. Viral interference between hepatitis B, C, and D viruses in dual and triple infections in HIV-positive patients.
Morsica G; Bagaglio S; Cicconi P; Capobianchi MR; Pellizzer G; Caramello P; Orani A; Moioli C; Rizzardini G; Uberti-Foppa C; Puoti M; Monforte AD;
J Acquir Immune Defic Syndr; 2009 Aug; 51(5):574-81. PubMed ID: 19590432
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis B or hepatitis C co-infection in individuals infected with human immunodeficiency virus and effect of anti-tuberculosis drugs on liver function.
Padmapriyadarsini C; Chandrabose J; Victor L; Hanna LE; Arunkumar N; Swaminathan S
J Postgrad Med; 2006; 52(2):92-6. PubMed ID: 16679670
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of hepatitis B and C virus co-infection in HIV positive patients attending a health institution in southeast Nigeria.
Nnakenyi ID; Uchechukwu C; Nto-Ezimah U
Afr Health Sci; 2020 Jun; 20(2):579-586. PubMed ID: 33163019
[TBL] [Abstract][Full Text] [Related]
39. Toll-like receptors and hepatitis C virus infection.
Gao Y; Nepal N; Jin SZ
Hepatobiliary Pancreat Dis Int; 2021 Dec; 20(6):521-529. PubMed ID: 34419367
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
